Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
2.
Adv Exp Med Biol ; 1114: 49-55, 2018.
Article in English | MEDLINE | ID: mdl-29679364

ABSTRACT

Ischemic heart disease (IHD) is a frequent accompaniment of chronic obstructive pulmonary disease (COPD). Co-occurrence of these two diseases is associated with many risk factors, difficulties in implementing appropriate therapies, numerous complications, and high spending for treatment. All these elements significantly reduce the quality of life of patients. The aim of this study was to estimate the expenditure for medications involved with IHD pharmacotherapy in the course of COPD. This retrospective study was based on the review of medical files of 57 patients, 27 women and 30 men, diagnosed with IHD, according to the severity classification, in the course of COPD which was staged according to the GOLD criteria. We found a considerable increase in per capita per year retail spending for drugs. The spending increased with the severity class of IHD; from 27.41 EUR in Class I to 142.30 EUR in Class IV. This spending did not include the treatment cost for the basic disease, i.e., COPD. A high individual cost burden was decreased by a discounting intervention of the National Health Fund. Despite a relatively high drug expenditure, we consider the treatment being cost-effective since we noticed a reduction in the classical risk factors for IHD, related to metabolic disturbances and lifestyle features, as soon as 2 months after treatment initiation. This study confirms that heart disease accompanying COPD is a frequent occurrence, generating high costs of treatment, which relates to the severity of this comorbidity.


Subject(s)
Drug Costs , Health Expenditures , Myocardial Ischemia/drug therapy , Myocardial Ischemia/economics , Pulmonary Disease, Chronic Obstructive/drug therapy , Pulmonary Disease, Chronic Obstructive/economics , Female , Humans , Male , Myocardial Ischemia/complications , Pulmonary Disease, Chronic Obstructive/complications , Quality of Life , Retrospective Studies
3.
Drug Des Devel Ther ; 11: 1849-1857, 2017.
Article in English | MEDLINE | ID: mdl-28694685

ABSTRACT

The study was conducted to evaluate the effects of platelet-rich plasma (PRP), supernatant of PRP (SPRP) obtained by centrifugation, and supernatant of activated PRP (SActi-PRP) obtained by Ca2+ solution-treated PRP on collagen biosynthesis, prolidase activity, and ß1-integrin signaling in cultured human skin fibroblasts. Incubation of fibroblasts with 5% PRP for 24 h contributed to ~5-fold increase in collagen biosynthesis compared to the control. In the cells treated with 5% of SPRP or SActi-PRP, collagen biosynthesis showed a 3-fold increase of the control. PRP, SPRP, and SActi-PRP stimulated prolidase activity similar to collagen biosynthesis. Collagen biosynthesis and prolidase activity are regulated by ß1-integrin receptor signaling. Incubation of fibroblasts with PRP for 24 h contributed to a dose-dependent increase in the expression of ß1-integrin receptor, while SActi-PRP increased the process to a much lower extent. SPRP had no effect on the ß1-integrin receptor expression. All the studied fractions of blood increased the expression of FAK as well as the expression of phosphorylated MAP-kinases. However, PRP was found to be the most effective stimulator of expression of these particular kinases. These studies suggest that a complex of factors, including growth factors, adhesion molecules, and prolidase contained in PRP, all evoke growth and collagen-promoting activities in human dermal fibroblasts.


Subject(s)
Collagen/biosynthesis , Dipeptidases/metabolism , Fibroblasts/metabolism , Integrin beta1/drug effects , Platelet-Rich Plasma/chemistry , Skin/metabolism , Cells, Cultured , DNA/biosynthesis , Dose-Response Relationship, Drug , Fibroblasts/drug effects , Fibroblasts/enzymology , Focal Adhesion Kinase 1/biosynthesis , Focal Adhesion Kinase 1/genetics , Humans , Mitogen-Activated Protein Kinases/metabolism , Signal Transduction/drug effects , Skin/cytology , Skin/drug effects
4.
Drug Des Devel Ther ; 11: 669-676, 2017.
Article in English | MEDLINE | ID: mdl-28293103

ABSTRACT

AIM: The aim of this study was to evaluate the effect of ethanol and hyaluronic acid (HA) on cell survival and apoptosis in cultured human skin fibroblasts. Regarding the mechanism of ethanol action on human skin fibroblasts, we investigated cell viability and apoptosis, expression of focal adhesion kinase (FAK), and the influence of HA on those processes. MATERIALS AND METHODS: Studies were conducted in confluent human skin fibroblast cultures that were treated with 25 mM, 50 mM, and 100 mM ethanol or with ethanol and 500 µg/mL HA. Cell viability was examined using methyl thiazolyl tetrazolium (MTT) assay and NC-300 Nucleo-Counter. Imaging of the cells using a fluorescence microscope Pathway 855 was performed to measure FAK expression. RESULTS: Depending on the dosage, ethanol decreased cell viability and activated the process of apoptosis in human skin fibroblasts. HA prevented the negative influence of ethanol on cell viability and prevented apoptosis. The analysis of fluorescence imaging using BD Pathway 855 High-Content Bioimager showed the inhibition of FAK migration to the cell nucleus, depending on the increasing concentration of ethanol. CONCLUSION: This study proves that downregulation of signaling pathway of FAK is involved in ethanol-induced apoptosis in human skin fibroblasts. The work also indicates a protective influence of HA on FAK activity in human skin fibroblasts exposed to ethanol.


Subject(s)
Ethanol/pharmacology , Fibroblasts/drug effects , Fibroblasts/enzymology , Focal Adhesion Protein-Tyrosine Kinases/metabolism , Hyaluronic Acid/pharmacology , Skin/cytology , Adult , Apoptosis/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Hyaluronic Acid/administration & dosage , Structure-Activity Relationship
5.
Mol Cell Biochem ; 427(1-2): 13-22, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27995416

ABSTRACT

The aim of our study was to determine whether the use of cisplatin in the presence echistatin in MDA-MB-231 breast cancer cells leads to a reduction of toxic effects associated with the use of cisplatin. The expression of ß1-integrin and insulin-like growth factor 1 receptor (IGF-IR), signaling pathway protein expression: protein kinase B (AKT), mitogen-activated protein kinases (ERK1/ERK2), nuclear factor kappa B (NFκB), and caspase-3 and -9 activity was measured after 24 h of incubation with tested compounds to explain detailed molecular mechanism of induction of apoptosis. The viability of MDA-MB-231 breast cancer cells was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Annexin V-FITC/propidium iodide staining assay was performed to detect the induction of apoptosis. Inhibition DNA biosynthesis was determined by [3H]thymidine incorporation into DNA. The expression of of ß1-integrin, IGF-IR, AKT, ERK1/ERK2, NFκB, caspase-3 and -9 was evaluated using Western blot. The results suggest that treatment of MDA-MB-231 breast cancer cells for 24 h cisplatin plus echistatin severely inhibits cell growth and activates apoptosis by upregulation of caspase-3 and -9 expressions. The effect was stronger than treatment cisplatin and echistatin alone. In this study, we have found that cisplatin plus echistatin treatment decreases collagen biosynthesis in MDA-MB-231 breast cancer cells stronger than the individual compounds. The inhibition was found to be dependent on the ß1-integrin and IGF receptor activation. A significant reduction of ERK1/ERK2, AKT expression in cancer cells after cisplatin plus echistatin treatment was also found. The cancer cells treated by echistatin, cisplatin, and in particular the combination of both compounds drastically increased expression of NFκB transcription factor. Our results suggest that combined therapy cisplatin plus echistatin is a possible way to improve selectiveness of cisplatin. This mechanism probably is due to downregulation of expression of ß1-integrin and IGF-IR receptors, and the signaling pathway proteins induced by these receptors. Our results suggest that therapy cisplatin plus echistatin is a possible way to improve selectiveness of cisplatin.


Subject(s)
Breast Neoplasms/drug therapy , Cisplatin/pharmacology , Peptides/pharmacology , Breast Neoplasms/metabolism , Breast Neoplasms/pathology , Cell Line, Tumor , Cisplatin/agonists , Drug Synergism , Female , Humans , Intercellular Signaling Peptides and Proteins , Neoplasm Proteins/metabolism , Peptides/agonists
6.
Acta Pol Pharm ; 73(1): 239-45, 2016.
Article in English | MEDLINE | ID: mdl-27008818

ABSTRACT

The aim of this study was to assess the correlation between the costs of controlled and uncontrolled asthma therapy in outpatients care. To determine the efficacy of the medicinal care there was performed a retrospective study on a group of 150 patients. Thirty eight patients have been enrolled to study group. Drug costs were estimated on the basis of documentation of patients. The assessment takes into account the cost of the retail price of drugs, the cost of diagnostic tests and outpatient care. Evaluation of the costs of treatment of patients was performed from a societal perspective. In the study there was calculated the value of the daily, monthly and annual treatment of the patient depending on the degree of asthma control. There was analyzed the frequency of reception of certain preparations in the study group. It was compared the annual cost of therapy for the given preparation in both examined groups. The total annual costs of therapy in patients with controlled and uncontrolled asthma were compared. Properly controlled asthma is potential source of savings. Treatment of asthma in an outpatient setting allow to avoid exacerbation of the disease, reducing and limiting direct and indirect costs of disease and improving the quality of patient's life.


Subject(s)
Asthma/drug therapy , Health Care Costs , Adult , Aged , Female , Humans , Male , Middle Aged , Outpatients , Retrospective Studies
7.
Drug Des Devel Ther ; 9: 6225-33, 2015.
Article in English | MEDLINE | ID: mdl-26648698

ABSTRACT

INTRODUCTION: The aim of the study was to evaluate the effect of ethanol on collagen biosynthesis in cultured human skin fibroblasts, and the role of hyaluronic acid (HA) in this process. Regarding the mechanism of ethanol action on human skin fibroblasts we investigated: expression of ß1 integrin and insulin-like growth factor 1 receptor (IGF-IR), signaling pathway protein expression: mitogen-activated protein kinases (MAPKs), protein kinase B (Akt), nuclear factor kappa B (NF-κB) transcription factor, cytotoxicity assay and apoptosis, metalloproteinase activity, as well as the influence of HA on these processes. MATERIALS AND METHODS: Collagen biosynthesis, activity of prolidase, DNA biosynthesis, and cytotoxicity were measured in confluent human skin fibroblast cultures that have been treated with 25, 50, and 100 mM ethanol and with ethanol and 500 µg/mL HA. Western blot analysis and zymography were performed to evaluate expression of collagen type I, ß1 integrin receptor, IGF-IR, NF-κB protein, phospho-Akt protein, kinase MAPK, caspase 9 activity, and matrix metalloproteinases (MMP-9 and MMP-2). RESULTS: Ethanol in a dose-dependent manner lead to the impairment of collagen biosynthesis in fibroblast cultures through decreasing prolidase activity and expression of ß1 integrin and IGF-IR. This was accompanied by an increased cytotoxicity, apoptosis and lowered expression of the signaling pathway proteins induced by ß1 integrin and IGF-IR, that is, MAPK (ERK1/2) kinases. The lowered amount of synthesized collagen and prolidase activity disturbance may also be due to the activation of NF-κB transcription factor, which inhibits collagen gene expression. It suggests that the decrease in fibroblast collagen production may be caused by the disturbance in its biosynthesis but not degradation. The application of HA has a protective effect on disturbances caused by the examined substances. It seems that regulatory mechanism of ethanol-induced collagen aberration take place at the level of collagen biosynthesis, since no effect of ethanol and HA was found on process of collagen degradation by MMP-2 and MMP-9. CONCLUSION: This study provides evidence that ethanol impairs collagen metabolism in human skin fibroblasts, leading to a significant decrease in the amount of produced protein. This mechanism probably is due to downregulation of prolidase activity, expression of ß1 integrin and IGF-IR receptors, and the signaling pathway proteins induced by these receptors.


Subject(s)
Collagen/biosynthesis , Ethanol/antagonists & inhibitors , Fibroblasts/drug effects , Fibroblasts/metabolism , Hyaluronic Acid/pharmacology , Cell Survival/drug effects , Cells, Cultured , Collagen/metabolism , Dipeptidases/antagonists & inhibitors , Dipeptidases/metabolism , Dose-Response Relationship, Drug , Ethanol/pharmacology , Humans , Integrin beta1/metabolism , Receptor, IGF Type 1/antagonists & inhibitors , Receptor, IGF Type 1/metabolism , Signal Transduction/drug effects , Structure-Activity Relationship
8.
Drug Des Devel Ther ; 8: 1923-8, 2014.
Article in English | MEDLINE | ID: mdl-25342885

ABSTRACT

AIM: The aim of this study was to evaluate the effect of caffeine on collagen biosynthesis in human skin fibroblasts and the influence of hyaluronic acid (HA) on this process. MATERIALS AND METHODS: Collagen, [(3)H]-thymidine incorporation, and prolidase activity were measured in confluent human skin fibroblast cultures that had been treated with 1, 2, and 5 mM caffeine and with caffeine and 500 µg/mL HA. Western immunoblot analysis was performed to evaluate expression of ß1-integrin receptor, insulin-like growth factor receptor phospho-Akt protein and mitogen-activated protein kinase (phospho-extracellular signal-regulated kinase). RESULTS: Caffeine inhibited collagen biosynthesis in a dose-dependent manner. The mechanism of this process was found at the level of prolidase activity. Caffeine significantly inhibited the enzyme activity. The addition of HA had no effect on collagen biosynthesis or prolidase activity in fibroblasts incubated with caffeine. Caffeine also had an inhibitory effect on DNA biosynthesis. HA, however, did not have any significant effect on this process. The inhibition of the expression of ß1-integrin and insulin-like growth factor receptor in fibroblasts incubated with the caffeine indicates a possible mechanism of inhibition of collagen biosynthesis. CONCLUSION: Caffeine reduces collagen synthesis in human cultured skin fibroblasts. HA did not have any significant protective effect on this process. This is the first study to our knowledge that reports caffeine-induced inhibition of collagen synthesis in human skin fibroblasts.


Subject(s)
Caffeine/pharmacology , Collagen/biosynthesis , Fibroblasts/drug effects , Fibroblasts/metabolism , Hyaluronic Acid/pharmacology , Skin/cytology , Caffeine/chemistry , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Hyaluronic Acid/chemistry , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...